PBI-4050 DECREASES HEPATIC STELLATE CELL ACTIVATION AND AMELIORATES FIBROSIS IN CARBON TETRACHLORIDE (CCL4)-INDUCED HEPATIC FIBROSIS MODEL

被引：1
|
作者：
Sarra-Bournet, F. [1 ]
Grouix, B. [1 ]
Hince, K. [1 ]
Felton, A. [1 ]
Tremblay, M. [1 ]
Abbott, S. [1 ]
Duceppe, J-S [1 ]
Zacharie, B. [1 ]
Laurin, P. [1 ]
Gagnon, L. [1 ]
机构：
[1] Promet Biosci Inc, Laval, PQ, Canada
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01358-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-405
引用
收藏
页码：S707 / S707
页数：1
相关论文
共 50 条
  • [1] Oral Treatment with PBI-4050 Reduces Fibrosis in Carbon Tetrachloride (CCl4)-Induced Hepatic Fibrosis
    Grouix, Brigitte
    Hince, Kathy
    Sarra-Bournet, Franois
    Felton, Alexandra
    Tremblay, Mikael
    Abbott, Shaun
    Duceppe, Jean-Simon
    Zacharie, Boulos
    Laurin, Pierre
    Gagnon, Lyne
    HEPATOLOGY, 2014, 60 : 418A - 418A
  • [2] PBI-4547 decreases hepatic stellate cell activation via AMPK signaling pathway, and reduces fibrosis in carbon tetrachloride (CCL4)-induced hepatic fibrosis model
    Sarra-Bournet, Francois
    Grouix, B.
    Hince, K.
    Felton, A.
    Tremblay, Mikael
    Abbott, S.
    Duceppe, J. -S.
    Zacharie, B.
    Laurin, P.
    Gagnon, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S408 - S408
  • [3] ORAL TREATMENT WITH PBI-4425 DECREASES FIBROSIS IN CARBON TETRACHLORIDE (CCL4)-INDUCED HEPATIC FIBROSIS MODEL
    Grouix, B.
    Sarra-Bournet, F.
    Hince, K.
    Felton, A.
    Tremblay, M.
    Abbott, S.
    Duceppe, J. -S.
    Zacharie, B.
    Laurin, P.
    Gagnon, L.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S228 - S229
  • [4] PBI-4050 inhibits hepatic stellate cell activation, restores autophagy, and reduces CCl4-induced liver fibrosis
    Grouix, Brigitte
    Sarra-Bournet, Francois
    Geerts, Lilianne
    Hince, Kathy
    Tremblay, Mikael
    Felton, Alexandra
    Blais, Alexandra
    Ouboudinar, Jugurtha
    Simard, Jean-Christophe
    Laurin, Pierre
    Gagnon, Lyne
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E194 - E194
  • [5] PBI-4050 Inhibits Hepatic Stellate Cell Proliferation and Activation Via AMPK, and Improves Hepatic Fibrosis in CCl4-Induced Liver Injury Model
    Sarra-Bournet, Francois
    Grouix, Brigitte
    Ouboudinar, Jugurtha
    Hince, Kathy
    Tremblay, Mikael
    Felton, Alexandra
    Simard, Jean-Christophe
    Laurin, Pierre
    Gagnon, Lyne
    HEPATOLOGY, 2017, 66 : 218A - 218A
  • [6] PBI-4050 promotes hepatic stellate cell deactivation by shifting energy metabolism
    Grouix, Brigitte
    Sarra-Bournet, Francois
    Simard, Jean-Christophe
    Thibodeau, Jean-Francois
    Leduc, Martin
    Gagnon, Lyne
    JOURNAL OF HEPATOLOGY, 2020, 73 : S509 - S509
  • [7] Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
    Liu, Ya-Wei
    Chiu, Yung-Tsung
    Fu, Shu-Ling
    Huang, Yi-Tsau
    JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
  • [8] Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
    Ya-Wei Liu
    Yung-Tsung Chiu
    Shu-Ling Fu
    Yi-Tsau Huang
    Journal of Biomedical Science, 22
  • [9] Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats
    Guo, Youjia
    Liang, Xingmei
    Meng, Mingyu
    Chen, Hongxia
    Wei, Xiaojie
    Li, Mingyan
    Li, Juman
    Huang, Renbin
    Wei, Jinbin
    PHYTOMEDICINE, 2017, 33 : 28 - 35
  • [10] REVERSIBILITY OF CCL4 INDUCED HEPATIC FIBROSIS IN RAT
    MOLNAR, Z
    MEHES, G
    VARGA, F
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1966, 29 (3-4): : 355 - &
12345